During the 45-day comment period, which was open from 04/30/2020 through 06/15/2020, the DME MACs received a total of 3 comments from 2 commenters.
Introduction to Responses
The DME MACs appreciate the comments received from stakeholders during the open comment period on the proposed External Infusion Pumps Local Coverage Determination (LCD).
Pursuant to the CMS Program Integrity Manual (CMS Pub. 100-08) Chapter 13:
In conducting a review, MACs shall use the available evidence of general acceptance by the medical community, such as published original research in peer-reviewed medical journals, systematic reviews and meta-analyses, evidence-based consensus statements and clinical guidelines.
Accordingly, the final policy and our response to comments are based on the best currently available published clinical evidence, to support optimal health outcomes in Medicare beneficiaries with a diagnosis of primary immunodeficiency diseases (PIDD).